Terns Pharmaceuticals Inc (NASDAQ: TERN) on Tuesday, soared 7.64% from the previous trading day, before settling in for the closing price of $19.12. Within the past 52 weeks, TERN’s price has moved between $1.87 and $19.98.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 16.38%. The company achieved an average annual earnings per share of 1.36%. With a float of $73.06 million, this company’s outstanding shares have now reached $87.51 million.
Terns Pharmaceuticals Inc (TERN) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Terns Pharmaceuticals Inc is 16.52%, while institutional ownership is 84.04%. The most recent insider transaction that took place on Nov 04 ’25, was worth 441,360. In this transaction Director of this company sold 24,520 shares at a rate of $18.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 04 ’25, when Company’s Director proposed sale 24,520 for $14.03, making the entire transaction worth $344,016.
Terns Pharmaceuticals Inc (TERN) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.24 earnings per share (EPS) for the period topping the consensus outlook (set at -0.3) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.65% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Terns Pharmaceuticals Inc (TERN) is currently performing well based on its current performance indicators. A quick ratio of 19.52 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
The latest stats from [Terns Pharmaceuticals Inc, TERN] show that its last 5-days average volume of 3.4 million was superior to 1.47 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 95.64%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 97.43%, which indicates a significant increase from 96.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.43 in the past 14 days, which was higher than the 0.56 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.28, while its 200-day Moving Average is $5.42. Now, the first resistance to watch is $21.49. This is followed by the second major resistance level at $22.40. The third major resistance level sits at $23.77. If the price goes on to break the first support level at $19.21, it is likely to go to the next support level at $17.84. The third support level lies at $16.93 if the price breaches the second support level.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
Market capitalization of the company is 1.85 billion based on 87,511K outstanding shares. Right now, sales total 0 K and income totals -88,850 K. The company made 0 K in profit during its latest quarter, and -24,090 K in sales during its previous quarter.
